| Literature DB >> 30091163 |
Luisa Sisinni1, Mercedes Pineda2, Maria Josep Coll3, Laura Gort3, Eulalia Turon4, Montserrat Torrent1, Anna Ey5, Eva Tobajas6, Isabel Badell1.
Abstract
Mucopolysaccharidosis type VII (MPS VII) is an inherited disease characterized by the cellular accumulation of undegraded GAGs due to the deficiency of the lysosomal enzyme β-glucuronidase. We describe a case of a 2-year-old female affected by a moderate form of MPS VII and submitted twice to HSCT with the aim of stabilizing skeletal problems and preventing neurocognitive alterations. The child underwent a second transplantation due to the rejection of the graft after a reduced-intensity conditioning in the first transplant. A myeloablative regimen allowed to achieve a stable full donor engraftment and normal enzyme levels during the 6 years of follow-up. Clinically, we observed stabilization of skeletal deformities and normal neurocognitive development. This is one of the few reports of mucopolysaccharidosis type VII treated with allogeneic HSCT.Entities:
Keywords: developmental; genetics; haematopoietic stem cell transplantation; metabolic disorders; neurology
Mesh:
Year: 2018 PMID: 30091163 DOI: 10.1111/petr.13278
Source DB: PubMed Journal: Pediatr Transplant ISSN: 1397-3142